Min Tu

Min Tu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Cancer Letters
Verified
Journal Article
Closed access
LMLing-Dong Meng
Ling-Dong Meng
GSGuo-Dong Shi
Guo-Dong Shi
WGWan-Li Ge
Wan-Li Ge
XHXu-Min Huang
Xu-Min Huang
QCQun Chen
Qun Chen
KJKuirong Jiang
Kuirong Jiang

1 June 2022 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
LMLingdong Meng
Lingdong Meng
YZYihan Zhang
Yihan Zhang
PWPengfei Wu
Pengfei Wu
DLDanrui Li
Danrui Li
YLYichao Lu
Yichao Lu
KJKuirong Jiang
Kuirong Jiang
Background: circular RNAs (circRNAs) have been reported to play crucial roles in the biology of different cancers. However, little is known about the function of circSTX6 (hsa_circ_0007905) in pancreatic ductal adenocarcinoma (PDAC). Methods: circSTX6, a circRNA containing exons 4, 5, 6 and 7 of the STX6 gene, was identified by RNA sequencing and detected by quantitative reverse transcription PCR (qRT–PCR). The biological function of circSTX6 was assessed in vitro and in vivo. The relationship between circSTX6 and miR-449b-5p was confirmed by biotin-coupled circRNA capture, fluorescence in situ hybridization (FISH) and luciferase reporter assays. The interaction of circSTX6 with Cullin 2 (CUL2) was verified by RNA–protein RNA pull-down, RNA immunoprecipitation (RIP) and western blotting assays. Results: circSTX6 was frequently upregulated in PDAC tissues, and circSTX6 overexpression promoted tumor proliferation and metastasis both in vitro and in vivo. Furthermore, circSTX6 expression was associated with tumor differentiation and N stage. Mechanistically, circSTX6 regulated the expression of non-muscle myosin heavy chain 9 (MYH9) by sponging miR-449b-5p. Moreover, circSTX6 was confirmed to participate in the ubiquitin-dependent degradation of hypoxia-inducible factor 1-alpha (HIF1A) by interacting with CUL2 and subsequently accelerating the transcription of MYH9. Conclusions: Our findings indicate that circSTX6 facilitates proliferation and metastasis of PDAC cells by regulating the expression of MYH9 through the circSTX6/miR-449b-5p axis and circSTX6/CUL2/HIF1A signaling pathway. Therefore, circSTX6 could serve as a potential therapeutic target for the treatment of PDAC.

20 April 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SDShangnan Dai
Shangnan Dai
YPYunpeng Peng
Yunpeng Peng
GWGuangfu Wang
Guangfu Wang
LYLingdi Yin
Lingdi Yin
HYHan Yan
Han Yan
YMYi Miao
Yi Miao
Background: Delayed gastric emptying (DGE) is a common complication after pancreaticoduodenectomy (PD) or pylorus preserving pancreaticoduodenectomy (PPPD). However, its risk factors are still unclear. This meta-analysis aimed to identify the potential risk factors of DGE among patients undergoing PD or PPPD. Methods: We searched PubMed, EMBASE, Web of Science, Cochrane Library, Google Scholar and ClinicalTrial.gov for studies that examined the clinical risk factors of DGE after PD or PPPD from inception through July 31, 2022. We pooled odds ratios (ORs) with 95% confidence intervals (CIs) using random-effects or fixed-effects models. We also performed heterogeneity, sensitivity, and publication bias analyses. Results: The study included a total of 31 research studies, which involved 9205 patients. The pooled analysis indicated that out of 16 non-surgical related risk factors, three risk factors were found to be associated with an increased incidence of DGE. These risk factors were older age (OR 1.37, P=0.005), pre-operative biliary drainage (OR 1.34, P=0.006), and soft pancreas texture (OR 1.23, P=0.04). On the other hand, patients with dilated pancreatic duct (OR 0.59, P=0.005) had a decreased risk of DGE. Among 12 operation related risk factors,more blood loss (OR 1.33, P=0.01), post-operative pancreatic fistula (POPF) (OR 2.09, P<0.001), intra-abdominal collection (OR 3.58 , P=0.001), and intra-abdominal abscess (OR 3.06, P<0.0001) were more likely to cause DGE. However, our data also revealed 20 factors did not support stimulative factors influencing DGE. Conclusion: Age, pre-operative biliary drainage, pancreas texture, pancreatic duct size, blood loss, POPF, intra-abdominal collection and intra-abdominal abscess are significantly associated with DGE. This meta-analysis may have utility in guiding clinical practice for improvements for screening patients with high risk of DGE and selecting appropriate treatment measure.

21 March 2017 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
MTMin Tu
Min Tu
HLHaifeng Li
Haifeng Li
NLNan Lv
Nan Lv
CXChunhua Xi
Chunhua Xi
ZLZipeng Lu
Zipeng Lu
YMYi Miao
Yi Miao
Vasohibin 2 (VASH2) has previously been identified as an agiogenenic factor and a cancer related protein. Here we investigated the association of VASH2 expression and chemoresistance in pancreatic cancer. Immunohistochemical staining for VASH2 was performed on 102 human pancreatic cancer samples. Pancreatic cancer cell line models exhibiting overexpression or knockdown of VASH2 were generated. Gene expression analyses were carried out to determine genes differentially regulated by VASH2. Putative transcription factors that are downstream mediators of gene expression regulated by VASH2 were queried bioinformatically. Dual-luciferase reporter assays and ChIP assays were performed to confirm transactivation of target genes following VASH2 overexpression or knockdown. VASH2 protein expression was higher in human pancreatic cancer than in paired adjacent tissues and elevated VASH2 levels were associated with gemcitabine chemoresistance. In cell line models of pancreatic cancer, VASH2 expression induced gemcitabine chemoresistance in vitro and in vivo. It was discovered that expression of ribonucleotide reductase regulatory subunit M2 (RRM2) is regulated by VASH2; immunohistochemical analysis demonstrated a positive association of VASH2 expression and RRM2 expression in human pancreatic cancer tissues. Bioinformatics analyses revealed that induction of the Jun proto-oncogene (JUN) by VASH2 is responsible for upregulation of RRM2 expression; this JUN-dependent regulation of RRM2 by VASH2 was confirmed by chromatin immunoprecipitation and dual luciferase reporter assays, which demonstrated that JUN directly binds with the RRM2 promoter to activate transcription. These data suggest that VASH2 reduces the chemosensitivity to gemcitabine in pancreatic cancer cells via JUN-dependent transactivation of RRM2.

5 March 2012 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
QWQingguang Wang
Qingguang Wang
DXDong Xu
Dong Xu
CHChao Han
Chao Han
MTMin Tu
Min Tu
QDQing DU
Qing DU
LXLijian Xu
Lijian Xu
Serine/threonine-protein kinase-1 (SMG-1) belongs to the phosphatidylinositol 3‑kinase‑related kinase family. Altered expression of SMG-1 contributes to human carcinogenesis and cancer progression. The present study detected the expression levels of SMG-1 in normal and cancerous pancreatic tissues and then assessed the effects of SMG-1-knockdown in pancreatic cancer cell lines in vitro. A pancreatic cancer tissue array and pancreatic cancer cell lines were used to detect the expression levels of SMG-1 and a lentivirus expressing either SMG-1 or negative control short hairpin (sh)RNA were used to knock down the expression of SMG-1 in the pancreatic cancer cell lines. Western blot, cell proliferation, Cell Counting kit-8, Transwell tumor cell migration and invasion assays, and flow cytometric analysis of cell apoptosis with or without gemcitabine or cisplatin treatment were performed to assess the tumor cells. The protein expression of SMG-1 was higher in the pancreatic cancer tissues and cells compared with the normal tissues. sh-SMG-1 lentivirus infection significantly suppressed the expression of SMG-1 in the pancreatic cancer cell lines, resulting in the inhibition of tumor cell proliferation and increased chemosensitivity to treatment with gemcitabine and cisplatin. However, SMG-1 knockdown had no effect on pancreatic cancer cell migration or invasion capacities. The protein expression of SMG-1 was increased in the pancreatic cancer tissues and was associated with an advanced tumor stage. Knock down of the expression of SMG-1 inhibited tumor cell proliferation and induced the chemosensitivity of pancreatic cancer cells in vitro.

5 January 2022 in PeerJ
Verified
Journal Article
Open access
PDF file
CYChaozhi Yang
Chaozhi Yang
XWXuebing Wang
Xuebing Wang
CQChenjie Qiu
Chenjie Qiu
ZZZiruo Zheng
Ziruo Zheng
KLKai Lin
Kai Lin
WGWentao Gao
Wentao Gao
Pancreatic ductal adenocarcinoma (PDAC) is one of the common malignant tumors with high lethal rate and poor prognosis. Dysregulation of many genes have been reported to be involved in the occurrence and development of PDAC. However, as a highly conserved gene in eukaryotes, the role of Fasciculation and Elongation protein Zeta 2 (FEZ2) in pancreatic cancer progression is not clear. In this study, we identified the oncogenic effect of FEZ2 on PDAC. By mining of The Cancer Genome Atlas (TCGA) database, we found that FEZ2 was upregulated in PDAC tissues and FEZ2 expression was negatively regulated by its methylation. Moreover, high expression and low methylation of FEZ2 correlated with poor prognosis in PDAC patients. Besides, we found that FEZ2 could promote PDAC cells proliferation, migration and 5-FU resistance in vitro. Furthermore, Gene pathway enrichment analysis demonstrated a positive correlation between Wnt signaling activation and FEZ2 expression in PDAC patients. Western blot showed that FEZ2 knockdown significantly suppressed β-catenin expression. Collectively, our finding revealed that FEZ2 functioned as a potential oncogene on PDAC progression and migration, and the expression of FEZ2 had guidance value for the treatment and chemotherapy program of PDAC patients.